240 related articles for article (PubMed ID: 10602445)
1. Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial.
Gaubitz M; Schorat A; Schotte H; Kern P; Domschke W
Lupus; 1999; 8(9):731-6. PubMed ID: 10602445
[TBL] [Abstract][Full Text] [Related]
2. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
[TBL] [Abstract][Full Text] [Related]
3. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Dittrich K; Ross S; Benz K; Amann K; Dötsch J
Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
Kawazoe M; Kaneko K; Yamada Z; Masuoka S; Mizutani S; Yamada S; Shikano K; Sato H; Kaburaki M; Muraoka S; Kawai S; Nanki T
Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
Conti F; Ceccarelli F; Perricone C; Massaro L; Cipriano E; Pacucci VA; Truglia S; Miranda F; Morello F; Alessandri C; Spinelli FR; Valesini G
Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
Lourdudoss C; Vollenhoven Rv
Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
[TBL] [Abstract][Full Text] [Related]
8. Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil.
Laskari K; Zintzaras E; Tzioufas AG
Clin Exp Rheumatol; 2010; 28(1):83-6. PubMed ID: 20346244
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
Fassbinder T; Saunders U; Mickholz E; Jung E; Becker H; Schlüter B; Jacobi AM
Arthritis Res Ther; 2015 Apr; 17(1):92. PubMed ID: 25890338
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
Dall'Era M
Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy of mycophenolate mofetil for systemic lupus erythematosus].
Suzuki D; Ogawa N; Sawada J; Kimoto O; Shimoyama K; Hayashi H
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug; 32(4):263-8. PubMed ID: 19721347
[TBL] [Abstract][Full Text] [Related]
13. [Statement on the use of mycophenolate mofetil for systemic lupus erythematosus].
Aringer M; Fischer-Betz R; Hiepe F; ;
Z Rheumatol; 2013 Aug; 72(6):575-80. PubMed ID: 23756593
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
Pisoni CN; Karim Y; Cuadrado MJ
Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
Szyper-Kravitz M; Sheinberg P; Sidi Y; Schiffenbauer Y; Trubniykov E; Shoenfeld Y
Int Arch Allergy Immunol; 2005 Dec; 138(4):334-6. PubMed ID: 16224194
[TBL] [Abstract][Full Text] [Related]
16. Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase.
Mino Y; Naito T; Shimoyama K; Ogawa N; Kawakami J
J Clin Pharm Ther; 2012 Apr; 37(2):217-20. PubMed ID: 21517926
[TBL] [Abstract][Full Text] [Related]
17. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years.
Posalski JD; Ishimori Ml; Wallace DJ; Weisman MH
Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil treatment in children and adolescents with lupus.
Kazyra I; Pilkington C; Marks SD; Tullus K
Arch Dis Child; 2010 Dec; 95(12):1059-61. PubMed ID: 20810399
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
